Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site
M. Narwal, Harvijay Singh, Shivendra Pratap, et al.
International Journal of Biological Macromolecules (2018) Vol. 116, pp. 451-462
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Structural and Mechanistic Insights into the Main Protease (Mpro) Dimer Interface Destabilization Inhibitor: Unveiling New Therapeutic Avenues against SARS-CoV-2
Ankur Singh, Kuldeep Jangid, Sanketkumar Nehul, et al.
Biochemistry (2025)
Closed Access | Times Cited: 1
Advances and prospects on production of lactulose and epilactose by cellobiose 2-epimerases: A review
Bo Pang, Jiahao Yang, Manxi Song, et al.
International Journal of Biological Macromolecules (2025) Vol. 305, pp. 141283-141283
Closed Access | Times Cited: 1
Structural insights into RNA recognition by the Chikungunya virus nsP2 helicase
Yee-Song Law, Age Utt, Yaw Bia Tan, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 19, pp. 9558-9567
Open Access | Times Cited: 71
Green synthesis of nanometal impregnated biomass – antiviral potential
Shweta Choudhary, Ravi Kumar, Utsav Dalal, et al.
Materials Science and Engineering C (2020) Vol. 112, pp. 110934-110934
Closed Access | Times Cited: 57
Vaccine development for mosquito-borne viral diseases
Zhiwei Huang, Yuxuan Zhang, Hongyu Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Discovery of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach
Eric M. Merten, John D. Sears, Tina M. Leisner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach
Eric M. Merten, John D. Sears, Tina M. Leisner, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 42
Closed Access | Times Cited: 7
Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection
Benazir Fatma, Ravi Kumar, Vedita Anand Singh, et al.
Antiviral Research (2020) Vol. 179, pp. 104808-104808
Closed Access | Times Cited: 39
Structural insights into Entamoeba histolytica arginase and structure‐based identification of novel non‐amino acid based inhibitors as potential antiamoebic molecules
Anjali Malik, Vikram Dalal, Serge Ankri, et al.
FEBS Journal (2019) Vol. 286, Iss. 20, pp. 4135-4155
Open Access | Times Cited: 39
Small-Molecule Inhibitors of Chikungunya Virus: Mechanisms of Action and Antiviral Drug Resistance
Kristína Kováčiková, Martijn J. van Hemert
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 12
Open Access | Times Cited: 37
Evaluation of novobiocin and telmisartan for anti-CHIKV activity
Praveen Tripathi, Anjali Soni, Shiv Pratap Singh Yadav, et al.
Virology (2020) Vol. 548, pp. 250-260
Open Access | Times Cited: 33
The evolutionary and molecular history of a chikungunya virus outbreak lineage
Janina Krambrich, Filip Mihalič, Michael W. Gaunt, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 7, pp. e0012349-e0012349
Open Access | Times Cited: 4
A robust fluorogenic substrate for chikungunya virus protease (nsP2) activity
Sparsh Makhaik, Wioletta Rut, Shruti Choudhary, et al.
Protein Science (2025) Vol. 34, Iss. 3
Open Access
Synthesis, screening and validation of cysteine-reactive fragments as chikungunya virus protease inhibitors
Junming He, Henry Illingworth, Sven Ullrich, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130176-130176
Open Access
Novel peptide inhibitor for the Chikungunya virus nsP2 protease: Identification and Characterization.
Mohammadamin Mastalipour, Ian Gering, Mônika A. Coronado, et al.
Current Research in Microbial Sciences (2025) Vol. 8, pp. 100376-100376
Open Access
In vitro study of Hesperetin and Hesperidin as inhibitors of zika and chikungunya virus proteases
Raphael J. Eberle, Danilo S. Olivier, Carolina Colombelli Pacca, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0246319-e0246319
Open Access | Times Cited: 26
Targeting the nsp2 Cysteine Protease of Chikungunya Virus Using FDA Approved Library and Selected Cysteine Protease Inhibitors
Prateek Kumar, Deepak Kumar, Rajanish Giri
Pathogens (2019) Vol. 8, Iss. 3, pp. 128-128
Open Access | Times Cited: 26
Interdomain Flexibility of Chikungunya Virus nsP2 Helicase-Protease Differentially Influences Viral RNA Replication and Infectivity
Yee-Song Law, Sainan Wang, Yaw Bia Tan, et al.
Journal of Virology (2020) Vol. 95, Iss. 6
Open Access | Times Cited: 26
Identification and evaluation of antiviral potential of thymoquinone, a natural compound targeting Chikungunya virus capsid protein
Ravi Kumar, Sanketkumar Nehul, Ankur Singh, et al.
Virology (2021) Vol. 561, pp. 36-46
Open Access | Times Cited: 23
Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus
Beatriz Gois de Souza, Shweta Choudhary, Gabriel Gomes Vilela, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115572-115572
Closed Access | Times Cited: 7
1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors
Larisa Ivanova, Kai Rausalu, Eva Žusinaite, et al.
ACS Omega (2021) Vol. 6, Iss. 8, pp. 5786-5794
Open Access | Times Cited: 17
Novel Analogues of the Chikungunya Virus Protease Inhibitor: Molecular Design, Synthesis, and Biological Evaluation
Larisa Ivanova, Kai Rausalu, Maksim Ošeka, et al.
ACS Omega (2021) Vol. 6, Iss. 16, pp. 10884-10896
Open Access | Times Cited: 16
Repurposing of approved drug molecules for viral infectious diseases: a molecular modelling approach
Nandan Kumar, Himakshi Sarma, G. Narahari Sastry
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 17, pp. 8056-8072
Closed Access | Times Cited: 15
Pharmacological Potential of Flavonoids against Neurotropic Viruses
Juliana Helena Castro e Silva, Jéssica Teles Souza, Clarissa S. Schitine, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1149-1149
Open Access | Times Cited: 10
An Overview of Indian Biomedical Research on the Chikungunya Virus with Particular Reference to Its Vaccine, an Unmet Medical Need
Muhammed Muhsin Varikkodan, Faisal Kunnathodi, Sarfuddin Azmi, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1102-1102
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top